HYPR — Hyperfine Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Hyperfine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	188	117	75.2	37.6	35.1
Net Total Accounts Receivable
Net Total Receivables	0.658	2.6	4.13	8.3	6.52
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	197	129	88.9	53.7	50.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.75	3.25	3.24	3.46	2.87
Other Long Term Assets
Total Assets	202	134	94.2	58.9	55.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15.7	8.8	8.77	8.73	11.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	16.2	10.3	9.8	9.86	14.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	186	124	84.4	49	41
Total Liabilities & Shareholders' Equity	202	134	94.2	58.9	55.3
Total Common Shares Outstanding